What is the clinical evidence from this study?

Study design: Review. Population: Cardiovascular diseases. Intervention: CD36.

What question did this study set out to answer?

To elucidate the specific immunoregulatory mechanisms of scavenger receptor CD36 across prevalent cardiovascular conditions and assess its viability as a therapeutic target.

August 19, 2026Immunology

Immune Regulation of CD36 in Cardiovascular Diseases

View Full Paper

Ask AI

Bookmark

Key result

Review highlights CD36 as a key immunoregulatory driver and therapeutic target across cardiovascular diseases.

Key Points

To elucidate the specific immunoregulatory mechanisms of scavenger receptor CD36 across prevalent cardiovascular conditions and assess its viability as a therapeutic target.
Synthesized current literature examining CD36 function as both a lipid transporter and signaling receptor in cardiovascular immune cells.
Evaluated preclinical and clinical evidence on CD36-targeted therapeutics, including small-molecule inhibitors, monoclonal antibodies, and human deficiency phenotypes.
Identified CD36 as a central node integrating lipid metabolism and inflammatory signaling pathways that dictate immune cell fate, such as macrophage activation in atherosclerosis.
Highlighted translational opportunities alongside paradoxical findings from human CD36 deficiency models to guide the design of targeted immunometabolic interventions.

PICO

Population

Cardiovascular diseases

Exposure / Comparator

CD36

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

CD36 functions as a key node integrating metabolic and inflammatory pathways in cardiovascular pathophysiology, presenting a potential target for novel immunometabolism-based interventions.

Cite This Study

Zha et al. (2026) conducted a review in Cardiovascular diseases. CD36 was evaluated. This review highlights the immunoregulatory mechanisms of CD36 in cardiovascular diseases, detailing its effects on immune cells like macrophages and assessing its therapeutic potential.

synapsesocial.com/papers/6a858aaf03308d306e2d8036 https://doi.org/10.1111/imm.70167

View Full Paper

Ask AI

Bookmark

Implication

CD36 functions as a key node integrating metabolic and inflammatory pathways in cardiovascular pathophysiology, presenting a potential target for novel immunometabolism-based interventions.

Immune Regulation of CD36 in Cardiovascular Diseases

Key Points

PICO

Discussion

Implication

Cite This Study

Immune Regulation of CD36 in Cardiovascular Diseases

Key Points

PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider